Evaluation of Angiogenesis-Related Genes as Prognostic Biomarkers of Bevacizumab Treated Ovarian Cancer Patients: Results from the Phase IV MITO16A/ManGO OV-2 Translational Study

SIMPLE SUMMARY: The possibility to identify, with appropriate biomarkers, patients that might mostly benefit from any given treatment is the basis of personalized oncology. Cancer biomarkers should be properly identified and validated on a large number of patients possibly enrolled in dedicated clin...

Descripción completa

Detalles Bibliográficos
Autores principales: Califano, Daniela, Gallo, Daniela, Rampioni Vinciguerra, Gian Luca, De Cecio, Rossella, Arenare, Laura, Signoriello, Simona, Russo, Daniela, Ferrandina, Gabriella, Citron, Francesca, Losito, Nunzia Simona, Gargiulo, Piera, Simeon, Vittorio, Scambia, Giovanni, Cecere, Sabrina Chiara, Montella, Marco, Colombo, Nicoletta, Tognon, Germana, Bignotti, Eliana, Zannoni, Gian Franco, Canzonieri, Vincenzo, Ciucci, Alessandra, Spina, Anna, Scognamiglio, Giosuè, Del Sesto, Michele, Schettino, Clorinda, Piccirillo, Maria Carmela, Perrone, Francesco, Chiodini, Paolo, Pignata, Sandro, Baldassarre, Gustavo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8533892/
https://www.ncbi.nlm.nih.gov/pubmed/34680301
http://dx.doi.org/10.3390/cancers13205152

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8533892/
https://www.ncbi.nlm.nih.gov/pubmed/34680301
http://dx.doi.org/10.3390/cancers13205152

Ejemplares similares